Researchers at the University of Illinois at Chicago have identified a molecular switch that causes immune cells called macrophages to clean up cellular debris caused by infections instead of contributing to inflammation and tissue injury.
Their findings are reported in the journal Proceedings of the National Academy of Sciences.
Macrophages are a type of immune cell found throughout the body. These cells can produce inflammation, which is good in moderation because inflammatory signals bring other immune cells to a specific location to clear an infection. However, when inflammation gets out of control, as it can in cases of inflammatory diseases, it can cause excess cellular and tissue damage, contributing to a vicious cycle that is very difficult to reverse. But macrophages also play a significant role in reducing inflammation when they engulf cellular debris or foreign microbes that contribute to inflammation. The mechanism behind macrophages’ ability to switch back and forth between these two diametrically opposed roles has long-puzzled scientists.
Researchers led by Saroj Nepal, research assistant professor in the department of pharmacology at the UIC College of Medicine, have found that a molecule called Gas6 is required to induce macrophages to perform their anti-inflammatory role by engulfing and digesting cellular debris that can contribute to inflammation. The molecule could serve as a potential drug target for drug makers interested in coaxing the cells toward their anti-inflammatory state to help treat people.
In a mouse model of acute lung injury, Nepal and colleagues found that lung macrophages expressed both inflammatory and anti-inflammatory proteins. One of the anti-inflammatory proteins was Gas6. In a mouse model of acute lung injury where the animals’ macrophages were artificially depleted of Gas6, clearance of inflammatory molecules and proteins in the lungs was severely impaired, and the inflammation could not be resolved. When they artificially boosted levels of Gas6 in the mouse macrophages, inflammation was resolved much faster than in mice with normal macrophages.
“Harnessing the anti-inflammatory function of macrophages using the Gas6 switch holds great potential for treating diseases ranging from heart disease to cancer to rheumatoid arthritis, where inflammation is a key underlying feature,” Nepal said.
The Latest on: Macrophages
via Google News
The Latest on: Macrophages
- Macrophage subgroups may play pivotal role in COVID-19 lethalityon October 5, 2020 at 5:35 pm
Many researchers are attempting to identify risk factors for severe or critical COVID-19. A recent paper in the journal Medical Hypotheses in September 2020 suggests that macrophage class activation ...
- Glioblastoma-associated Microglia and Macrophages: Targets for Therapies to Improve Prognosison October 4, 2020 at 5:00 pm
A large proportion of the tumour microenvironment consists of an inflammatory infiltrate predominated by microglia and macrophages, which are thought to be subverted by glioblastoma cells for ...
- Glioblastoma-associated Microglia and Macrophages: Targets for Therapies to Improve Prognosison October 3, 2020 at 5:00 pm
Brain. 2017;140(6):1548-1560. Overall, monocyte-derived macrophages and CNS-intrinsic microglia are both represented within glioblastoma multiforme specimens in patients and in models. This has ...
- Autopsy Study Finds Most COVID-19 Patients Have Macrophages in Myocardiumon October 2, 2020 at 11:58 am
“The fact that the majority of patients are getting macrophages in the heart as part of their disease process, at least the ones who are dying . . . may explain why there are some cardiac functional ...
- Zebrafish embryos help prove what happens to nanoparticles in the bloodon September 30, 2020 at 10:24 am
With new results published in ACS Nano ("Tracing the In Vivo Fate of Nanoparticles with a Non-Self Biological Identity" and "Differential Nanoparticle Sequestration by Macrophages and Scavenger ...
- Schwann cells promote lung cancer proliferation by promoting the M2 polarization of macrophages.on September 28, 2020 at 12:49 am
The interplay between immune cells and tumor cells determines the fate of tumorigenesis. Targeting the abnormal immune response of tumors has been recently achieved great success in some patients.
- SARS-CoV-2 infects monocytes and macrophages, without cytopathic effecton September 19, 2020 at 5:00 pm
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected over 30 million individuals worldwide. Originating in Wuhan (China) at the end of 2019 ...
- Researchers discover a mechanism allowing immune cells to regulate obesityon September 17, 2020 at 5:00 pm
Macrophages are immune system cells. They are essential in the early response to infections, and they also have a key role in the proper functioning of our tissues and the regulation of obesity.
- Metabolic control of NLRP3 inflammasome by itaconationon September 17, 2020 at 2:54 pm
The Krebs cycle–derived immunometabolite itaconate constrains NLRP3 inflammasome activation and IL-1β release. Macrophages are innate immune cells that secure a first line of defense against a broad ...
- CNIC researchers discover a mechanism allowing immune cells to regulate obesityon September 17, 2020 at 8:20 am
Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) Macrophages are immune system cells. They are essential in the early response to infections, and they also have a key role ...
via Bing News